Status:
UNKNOWN
Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Pseudohermaphroditism
Eligibility:
All Genders
Brief Summary
To disclose the molecular pathology of our 3 families with 17βHSD3 deficiency.
Detailed Description
17βhydroxysteroid dehydrogenase 3 (17βHSD3) deficiency is a rare cause of male pseudohermaphroditism. The incidence is reported to be 1: 147,000 in the Netherlands. Fewer than one hundred affected 46,...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with 17β-hydroxysteroid dehydrogenase 3 deficiency and their family
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
August 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00173654
Start Date
August 1 2005
End Date
August 1 2006
Last Update
December 21 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan